Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30 count carton (NDC 63459-502-30), Rx only, Manufactured by: Cephalon, Inc., Salt Lake City, UT 84116
Published June 26, 2013 · Recall initiated: May 28, 2013
Summary
FDA records drug Class II recall D-606-2013, published June 26, 2013 and initiated May 28, 2013. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 316 cartons; Lot: Lot C88583, exp. 06/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification; during stability testing
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Distributor
- Product was distributed within the United States to FL, IL, MA, MO, MS, OH and TX. No government or foreign distribution.
- Lot
- Lot C88583, exp. 06/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAValganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, ManufacturedNovember 27, 2019
- FDAValacyclovir Hydrochloride Tablets, 1 g, 30 count bottle, Rx only manufactured in Israel by TevaFebruary 12, 2014
- FDAFluconazole Oral Suspension, 10 mg/mL, 35 ml bottle, RX only, Mfd by Cipla, Ltd., Goa, India, Dist by TevaJanuary 29, 2014
- FDACARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDCSeptember 11, 2013
- FDAVECURONIUM Bromide for Injection, 10 mg* per vial, *1 mg per mL when reconstituted to 10 mL, for IV single useJune 26, 2013
- FDANorpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottlesJune 26, 2013
Questions about this recall
Was Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30 count carton (NDC 63459-502-30), Rx only, Manufactured by: Cephalon, Inc., Salt Lake City, UT 84116 recalled?
Yes. FDA published recall D-606-2013 on June 26, 2013. Reported hazard: Failed Dissolution Specification; during stability testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter